Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,546 results for ""Antiphospholipid Syndrome""

Your Filters

Subject : covid-19
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Antiphospholipid syndrome in the era of COVID-19 - Two sides of a coin.

  • Authors : Mahroum N; International School of Medicine, Istanbul Medipol University, Istanbul, Turkey. Electronic address: .; Habra M

Subjects: Antibodies, Antiphospholipid*/Antibodies, Antiphospholipid*/Antibodies, Antiphospholipid*/immunology ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/immunology ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/complications

  • Source: Autoimmunity reviews [Autoimmun Rev] 2024 Sep; Vol. 23 (9), pp. 103543. Date of Electronic Publication: 2024 Apr 09.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128967 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome.

  • Authors : Aguirre Del-Pino R; Department of Rheumatology, Leiden University Medical Center (LUMC), Leiden, The Netherlands.; Division of Rheumatology, A Coruña University Hospital (CHUAC), Galicia, Spain.

Subjects: Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/complications ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/immunology ; Antibodies, Antiphospholipid*/Antibodies, Antiphospholipid*/Antibodies, Antiphospholipid*/blood

  • Source: Seminars in thrombosis and hemostasis [Semin Thromb Hemost] 2024 Sep; Vol. 50 (6), pp. 817-828. Date of Electronic Publication: 2024 Jan 16.Publisher: Thieme Country of Publication: United States NLM ID: 0431155 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Antiphospholipid syndrome, thrombosis, and vaccination in the COVID-19 pandemic.

  • Authors : Zekić T; Clinical Hospital Center Rijeka, Department of Rheumatology and Clinical Immunology, University of Rijeka, Faculty of Medicine, Rijeka, Croatia. .; University of Rijeka, Faculty of Medicine, 51000, Rijeka, Croatia. .

Subjects: Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/diagnosis ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/drug therapy ; COVID-19*/COVID-19*/COVID-19*/epidemiology

  • Source: Rheumatology international [Rheumatol Int] 2024 May; Vol. 44 (5), pp. 749-755. Date of Electronic Publication: 2024 Feb 23.Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Exploring the impact of acute viral exposure on clinical characteristics and antibody profiles in antiphospholipid syndrome: a study in CAPSTONE.

  • Authors : Wang C; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Beijing, 100730, China.; Jiang H

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/immunology ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/blood

  • Source: Clinical and experimental medicine [Clin Exp Med] 2024 Jun 18; Vol. 24 (1), pp. 130. Date of Electronic Publication: 2024 Jun 18.Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

SARS-CoV-2 vaccination appears to be safe in antiphospholipid antibody syndrome: Comment on evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations.

  • Authors : Singh K; Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India.; Misra DP

Subjects: Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/complications ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/diagnosis ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/drug therapy

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2023 Dec; Vol. 26 (12), pp. 2609-2611. Date of Electronic Publication: 2023 May 16.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

A young woman with acute coronary syndrome and antiphospholipid syndrome. Is it the antiphospholipid syndrome or COVID-19 vaccination or classical risk as the risk factor? a case report.

  • Authors : Siagian SN; Pediatric Cardiology and Congenital Heart Disease Division, Department of Cardiology and Vascular Medicine, National Cardiovascular Center Harapan Kita, Universitas Indonesia, Jakarta, Indonesia.; Christianto C

Subjects: Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/diagnosis ; Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/drug therapy ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/complications

  • Source: Journal of medical case reports [J Med Case Rep] 2024 Jan 19; Vol. 18 (1), pp. 47. Date of Electronic Publication: 2024 Jan 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-1947

Record details

Read More Add to Saved list
×
Editorial & Opinion

Comment on evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: A retrospective cohort study.

  • Authors : Tsai WH; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Liaw YP

Subjects: Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/complications ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/diagnosis ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/drug therapy

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2023 Sep; Vol. 26 (9), pp. 1869. Date of Electronic Publication: 2023 Feb 09.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

[Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future].

  • Authors : Nasonov EL; Nasonova Research Institute of Rheumatology.; Sechenov First Moscow State Medical University (Sechenov University).

Subjects: Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/complications ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/diagnosis ; Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/complications

  • Source: Terapevticheskii arkhiv [Ter Arkh] 2023 Jul 16; Vol. 95 (5), pp. 365-374. Date of Electronic Publication: 2023 Jul 16.Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Electronic Cited Medium: Print

Record details

Read More Add to Saved list
×
Academic Journal

Antiphospholipid antibody-related hepatic vasculitis in a juvenile after non-severe COVID-19: a case report and literature review.

  • Authors : Li Q; Tsinghua Medicine, School of Medicine, Tsinghua University, Beijing, China.; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.

Subjects: COVID-19*/COVID-19*/COVID-19*/complications ; COVID-19*/COVID-19*/COVID-19*/immunology ; Antibodies, Antiphospholipid*/Antibodies, Antiphospholipid*/Antibodies, Antiphospholipid*/blood

  • Source: Frontiers in immunology [Front Immunol] 2024 Apr 19; Vol. 15, pp. 1354349. Date of Electronic Publication: 2024 Apr 19 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development.

  • Authors : Müller-Calleja N; Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center, Mainz, Germany.; Institute of Clinical Chemistry and Laboratory Medicine, Johannes Gutenberg University Medical Center, Mainz, Germany.

Subjects: Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/complications ; COVID-19*/COVID-19*/COVID-19*/complications ; Virus Diseases*/Virus Diseases*/Virus Diseases*/complications

  • Source: Blood [Blood] 2024 Mar 21; Vol. 143 (12), pp. 1167-1180.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

Record details

Read More Add to Saved list
×
  • 1-10 of  1,546 results for ""Antiphospholipid Syndrome""